In normal conditions, neurofibromin binds RAS to regulate RAF-MEK-ERK activation of the MAPK pathway; however, mutations in the Nf1 gene result in reduced or absent neurofibromin activity in individuals with NF1, causing uncontrolled cell growth and tumor formation (Figure 1) [8]. The gene discussed is NF1; the disease is neoplasm.